VTGN - VistaGen Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $13.84. This is a potential upside of $10.09 (269.07%) from yesterday's end of day stock price of $3.75.

VistaGen Therapeutics's activity chart (see below) currently has 5 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 209 days.

Most recent stock forecast was given by ANDREW TSAI from JEFFERIES on 06-Dec-2023.

Best performing analysts who are covering VTGN - VistaGen Therapeutics:

Jason Mccarthy Andrew Tsai Brian Skorney Tim Lugo

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$15

$10.93 (268.55%)

$6

1 years 10 months 25 days ago
(06-Dec-2023)

1/3 (33.33%)

$10.13 (208.01%)

27

Buy

$30

$25.93 (637.10%)

$30

2 years 1 months 27 days ago
(04-Sep-2023)

0/2 (0%)

$23.79 (383.09%)

Hold

$9

3 years 3 months 10 days ago
(22-Jul-2022)

1/1 (100%)

$6.42 (248.84%)

809

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VTGN (VistaGen Therapeutics) average time for price targets to be met?

On average it took 209 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on VTGN (VistaGen Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the current lower performing score on VTGN (VistaGen Therapeutics) with a proven track record?

TIM LUGO

Which analyst has the most public recommendations on VTGN (VistaGen Therapeutics)?

Jason Mccarthy works at MAXIM GROUP and has 0 price targets and 0 ratings on VTGN

Which analyst is the currently most bullish on VTGN (VistaGen Therapeutics)?

Jason Mccarthy with highest potential upside - $25.93

Which analyst is the currently most reserved on VTGN (VistaGen Therapeutics)?

Brian Skorney with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?